Instructions to Authors
22 March 2020
Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of Cirrhosis
Meng Sha, Seogsong Jeong, Qiang Xia – 21 March 2020
Reply
Gerald Scott Winder, Sumeet K. Asrani – 21 March 2020
Is It Time to Consider Gut Microbiome Readouts for Precision Diagnosis and Treatment of Alcoholic Liver Disease?
Gail A.M. Cresci – 21 March 2020
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
Lorenzo D’Antiga – 20 March 2020
Use of Dual Hypothermic Oxygenated Machine Perfusion to Recover Extended Criteria Pediatric Liver Grafts
Davide Cussa, Damiano Patrono, Giorgia Catalano, Giorgia Rizza, Silvia Catalano, Alessandro Gambella, Francesco Tandoi, Renato Romagnoli – 20 March 2020
Renal Dysfunction After Liver Transplantation: Effect of Donor Type
Dagmar Kollmann, Shuet Fong Neong, Roizar Rosales, Bettina E. Hansen, Gonzalo Sapisochin, Stuart McCluskey, Mamatha Bhat, Mark S. Cattral, Les Lilly, Ian D. McGilvray, Anand Ghanekar, David R. Grant, Markus Selzner, Florence S. H. Wong, Nazia Selzner – 19 March 2020 – Recipients of donation after circulatory death (DCD) grafts are reportedly at higher risk of developing renal dysfunction after liver transplantation (LT).
Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
Helene Gellert‐Kristensen, Tom G. Richardson, George Davey Smith, Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Stefan Stender – 19 March 2020
Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican‐American Population of South Texas
Suet Ying Kwan, Jingjing Jiao, Jonathan Qi, Ying Wang, Peng Wei, Joseph B. McCormick, Susan P. Fisher‐Hoch, Laura Beretta – 19 March 2020 – Biomarkers to predict risk of liver fibrosis in subjects with nonalcoholic fatty liver disease, a common risk factor for hepatocellular carcinoma, would allow for early preventive interventions.
Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta–Activated Kinase 1–c‐Jun‐N‐Terminal Kinase/p38 Signaling
Junyong Wang, Junpeng Ma, Hongyu Nie, Xiao‐Jing Zhang, Peng Zhang, Zhi‐Gang She, Hongliang Li, Yan‐Xiao Ji, Jingjing Cai – 19 March 2020